Bhat, D. S., Spies, M. A. & Spies, M. A moving target for drug discovery: structure activity relationship and many genome (de)stabilizing functions of the RAD52 protein. DNA Repair 120, 103421 (2022).
Malacaria, E., Honda, M., Franchitto, A., Spies, M. & Pichierri, P. Physiological and pathological roles of RAD52 at DNA replication forks. Cancers 12, 402 (2020).
Malacaria, E. et al. Rad52 prevents excessive replication fork reversal and protects from nascent strand degradation. Nat. Commun. 10, 1412 (2019).
Murfuni, I. et al. Survival of the replication checkpoint deficient cells requires MUS81-RAD52 function. PLoS Genet. 9, e1003910 (2013).
Yeeles, J. T., Poli, J., Marians, K. J. & Pasero, P. Rescuing stalled or damaged replication forks. Cold Spring Harb. Perspect. Biol. 5, a012815 (2013).
Quinet, A., Lemacon, D. & Vindigni, A. Replication fork reversal: players and guardians. Mol. Cell 68, 830–833 (2017).
Kondratick, C. M., Washington, M. T. & Spies, M. Making choices: DNA replication fork recovery mechanisms. Semin. Cell Dev. Biol. 113, 27–37 (2021).
Carley, A. C. et al. Replication protein A phosphorylation facilitates RAD52-dependent homologous recombination in BRCA-deficient cells. Mol. Cell. Biol. 42, e0052421 (2022).
Stark, J. M., Pierce, A. J., Oh, J., Pastink, A. & Jasin, M. Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol. Cell. Biol. 24, 9305–9316 (2004).
Llorens-Agost, M. et al. POLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis. Nat. Cell Biol. 23, 1095–1104 (2021).
Mijic, S. et al. Replication fork reversal triggers fork degradation in BRCA2-defective cells. Nat. Commun. 8, 859 (2017).
Bhowmick, R., Minocherhomji, S. & Hickson, I. D. RAD52 facilitates mitotic DNA synthesis following replication stress. Mol. Cell 64, 1117–1126 (2016).
Sotiriou, S. K. et al. Mammalian RAD52 functions in break-induced replication repair of collapsed DNA replication forks. Mol. Cell 64, 1127–1134 (2016).
Cong, K. et al. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. Mol. Cell 81, 3128–3144.e3127 (2021).
Hanamshet, K., Mazina, O. M. & Mazin, A. V. Reappearance from obscurity: mammalian Rad52 in homologous recombination. Genes 7, 63 (2016).
Grimme, J. M. et al. Human Rad52 binds and wraps single-stranded DNA and mediates annealing via two hRad52-ssDNA complexes. Nucleic Acids Res. 38, 2917–2930 (2010).
Grimme, J. M. & Spies, M. FRET-based assays to monitor DNA binding and annealing by Rad52 recombination mediator protein. Methods Mol. Biol. 745, 463–483 (2011).
Kagawa, W. et al. Identification of a second DNA binding site in the human Rad52 protein. J. Biol. Chem. 283, 24264–24273 (2008).
Lloyd, J. A., McGrew, D. A. & Knight, K. L. Identification of residues important for DNA binding in the full-length human Rad52 protein. J. Mol. Biol. 345, 239–249 (2005).
Saotome, M. et al. Structural basis of homology-directed DNA repair mediated by RAD52. iScience 3, 50–62 (2018).
Mazina, O. M., Keskin, H., Hanamshet, K., Storici, F. & Mazin, A. V. Rad52 inverse strand exchange drives RNA-templated DNA double-strand break repair. Mol. Cell 67, 19–29.e13 (2017).
Bhat, D. S. et al. Therapeutic disruption of RAD52-ssDNA complexation via novel drug-like inhibitors. NAR Cancer 5, zcad018 (2023).
Hengel, S. R. et al. Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells. eLife 5, e14740 (2016).
Asor, R. & Kukura, P. Characterising biomolecular interactions and dynamics with mass photometry. Curr. Opin. Chem. Biol. 68, 102132 (2022).
Young, G. & Kukura, P. Interferometric scattering microscopy. Annu. Rev. Phys. Chem. 70, 301–322 (2019).
Balboni, B. et al. An integrative structural study of the human full-length RAD52 at 2.2 Å resolution. Commun. Biol. 7, 956 (2024).
Kagawa, W. et al. Crystal structure of the homologous-pairing domain from the human Rad52 recombinase in the undecameric form. Mol. Cell 10, 359–371 (2002).
Kinoshita, C. et al. The cryo-EM structure of full-length RAD52 protein contains an undecameric ring. FEBS Open Bio 13, 408–418 (2023).
Singleton, M. R., Wentzell, L. M., Liu, Y., West, S. C. & Wigley, D. B. Structure of the single-strand annealing domain of human RAD52 protein. Proc. Natl Acad. Sci. USA 99, 13492–13497 (2002).
Labute, P. LowModeMD—implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops. J. Chem. Inf. Model. 50, 792–800 (2010).
Cramer-Morales, K. et al. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood 122, 1293–1304 (2013).
Lok, B. H., Carley, A. C., Tchang, B. & Powell, S. N. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination. Oncogene 32, 3552–3558 (2013).
Feng, Z. et al. Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc. Natl Acad. Sci. USA 108, 686–691 (2011).
Rossi, M. J., DiDomenico, S. F., Patel, M. & Mazin, A. V. RAD52: paradigm of synthetic lethality and new developments. Front. Genet. 12, 780293 (2021).
Chandramouly, G. et al. Small-molecule disruption of RAD52 rings as a mechanism for precision medicine in BRCA-deficient cancers. Chem. Biol. 22, 1491–1504 (2015).
Sullivan, K. et al. Identification of a small molecule inhibitor of RAD52 by structure-based selection. PLoS ONE 11, e0147230 (2016).
Huang, F. et al. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors. Nucleic Acids Res. 44, 4189–4199 (2016).
Hengel, S. R., Spies, M. A. & Spies, M. Small-molecule inhibitors targeting DNA repair and DNA repair deficiency in research and cancer therapy. Cell Chem. Biol. 24, 1101–1119 (2017).
Stasiak, A. Z. et al. The human Rad52 protein exists as a heptameric ring. Curr. Biol. 10, 337–340 (2000).
Liang, C. C. et al. Mechanism of single-stranded DNA annealing by RAD52-RPA complex. Nature 629, 697–703 (2024).
Deveryshetty, J. et al. Homodecameric Rad52 promotes single-position Rad51 nucleation in homologous recombination. Preprint at bioRxiv https://doi.org/10.1101/2023.02.05.527205 (2023).
Honda, M., Okuno, Y., Yoo, J., Ha, T. & Spies, M. Tyrosine phosphorylation enhances RAD52-mediated annealing by modulating its DNA binding. EMBO J. 30, 3368–3382 (2011).
Rothenberg, E., Grimme, J. M., Spies, M. & Ha, T. Human Rad52-mediated homology search and annealing occurs by continuous interactions between overlapping nucleoprotein complexes. Proc. Natl Acad. Sci. USA 105, 20274–20279 (2008).
Kyriukha, Y. et al. The PALB2 DNA-binding domain is an intrinsically disordered recombinase. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-3235465/v1 (2023).
Deveryshetty, J. et al. Novel RNA and DNA strand exchange activity of the PALB2 DNA binding domain and its critical role for DNA repair in cells. eLife 8, e44063 (2019).
Henricksen, L. A., Umbricht, C. B. & Wold, M. S. Recombinant replication protein A: expression, complex formation, and functional characterization. J. Biol. Chem. 269, 11121–11132 (1994).
Bétous, R. et al. Substrate-selective repair and restart of replication forks by DNA translocases. Cell Rep. 3, 1958–1969 (2013).
Ling, J. A. et al. Fork-remodeling helicase Rad5 preferentially reverses replication forks with gaps in the leading strand. J. Mol. Biol. 435, 167946 (2023).
Subramanyam, S., Kinz-Thompson, C. D., Gonzalez, R. L. Jr. & Spies, M. Observation and analysis of RAD51 nucleation dynamics at single-monomer resolution. Methods Enzymol. 600, 201–232 (2018).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531–544 (2018).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).
Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D Struct. Biol. 74, 814–840 (2018).
Morin, A. et al. Collaboration gets the most out of software. eLife 2, e01456 (2013).
Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A. & Vriend, G. Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins 57, 678–683 (2004).
Krieger, E. & Vriend, G. New ways to boost molecular dynamics simulations. J. Comput. Chem. 36, 996–1007 (2015).
Dean, S. F., Whalen, K. L. & Spies, M. A. Biosynthesis of a novel glutamate racemase containing a site-specific 7-hydroxycoumarin amino acid: enzyme-ligand promiscuity revealed at the atomistic level. ACS Cent. Sci. 1, 364–373 (2015).
Subramanyam, S., Jones, W. T., Spies, M. & Spies, M. A. Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction. Nucleic Acids Res. 41, 9020–9032 (2013).
Whelan, D. R. & Rothenberg, E. Super-resolution mapping of cellular double-strand break resection complexes during homologous recombination. Proc. Natl Acad. Sci. USA 118, e2021963118 (2021).
